Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Clarithromycin × 90 days × Clear all

Phase

Phase 2 3 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Multiple Myeloma 1

Interventions

pembrolizumab 90 Carboplatin 53 Cyclophosphamide 49 Nivolumab 45 Specimen Handling 39 fludarabine 36 Magnetic Resonance Spectroscopy 36 Gemcitabine 35 Biopsy 35 Bevacizumab 35 Dexamethasone 33 Paclitaxel 32 Cisplatin 29 venetoclax 28 Temozolomide 28 atezolizumab 27 Injections 23 Irinotecan 22 Rituximab 21 Pemetrexed 21 Docetaxel 19 Radiotherapy 17 Prednisone 17 Lenalidomide 17 Fluorouracil 17 Cetuximab 17 durvalumab 16 Oxaliplatin 16 Azacitidine 16 abemaciclib 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02343042 2025-12-22

STOMP

Karyopharm Therapeutics Inc

Phase 1/2 Recruiting

Multiple Myeloma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡